Expression and activity of breast cancer resistance protein (BCRP) in de novo and relapsed acute myeloid leukemia.

被引：0
|
作者：
van der Kolk, DM
Vellenga, E
Scheffer, GL
Muller, M
Bates, SE
Scheper, RJ
de Vries, EGE
机构：
[1] Univ Groningen Hosp, Groningen, Netherlands
[2] Free Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
[3] Univ Wageningen, Wageningen, Netherlands
[4] NIH, NCI, Bethesda, MD USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2989
引用
收藏
页码：715A / 716A
页数：2
相关论文
共 50 条
  • [41] Downregulated STAG2 expression in de novo acute myeloid leukemia
    Han, Q.
    He, X.
    Wu, L.
    Gao, F.
    Ye, J.
    Wu, L.
    Chen, L.
    Jiang, X.
    Sun, M.
    Chen, S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1540 - 1540
  • [42] IDH inhibitors or chemotherapy in relapsed or refractory IDHmut acute myeloid leukemia.
    Murray, Graeme
    Bouligny, Ian Michael
    Patel, Tilak
    Doyel, Michael
    Boron, Josh
    Tran, Valerie
    Gor, Juhi
    Hang, Yiwei
    Ho, Thuy
    Zacholski, Kyle
    Venn, Chad Michael
    Alnimer, Yanal Mufeed
    Wages, Nolan
    Grant, Steven
    Maher, Keri Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [43] Pharmacokinetics and pharmacodynamics of gilteritinib in patients with relapsed or refractory acute myeloid leukemia.
    Smith, Catherine Choy
    Levis, Mark J.
    Litzow, Mark Robert
    Perl, Alexander E.
    Altman, Jessica K.
    Gill, Stan
    Yuen, Geoffrey
    Bonate, Peter
    Kadokura, Takeshi
    James, Angela Joubert
    Liu, Charles
    Nagase, Itsuro
    Fisniku, Ogert
    Bahceci, Erkut
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [44] The prognostic value of P-glycoprotein (ABCB) and breast cancer resistance protein (ABCG2) in adults with de novo acute myeloid leukemia with normal karyotype
    Damiani, Daniela
    Tiribelli, Mario
    Calistri, Elisabetta
    Geromin, Antonella
    Chiarvesio, Alexsia
    Michelutti, Angela
    Cavallin, Margherita
    Fanin, Renato
    HAEMATOLOGICA, 2006, 91 (06) : 825 - 828
  • [45] Expression of hBUB1 in acute myeloid leukemia.
    Lin, SF
    Lin, PM
    Yang, MC
    Liu, TC
    Chang, JG
    Sue, YC
    Chen, TP
    BLOOD, 2000, 96 (11) : 193B - 193B
  • [46] Analysis of gene expression patterns in acute myeloid leukemia.
    Alcalay, M
    Chiaradonna, F
    Pelicci, PG
    BLOOD, 1998, 92 (10) : 207B - 207B
  • [47] Expression of multidrug resistance 1, lung resistance protein and breast cancer resistance protein genes in chronic lymphocytic and chronic myelogeneous leukemia.
    Ural, A. Ugur
    Iseri, Ozlem Darcansoy
    Mutlu, Pelin Kaya
    Kars, Meltem Demirel
    Avcu, Ferit
    Gunduz, Ufuk
    Ilhan, Osman
    BLOOD, 2006, 108 (11) : 169B - 170B
  • [48] Clinical significance of MYC expression in acute myeloid leukemia.
    Ohanian, Maro
    Kantarjian, Hagop M.
    Rozovski, Uri
    Loghavi, Sanam
    Huh, Yang
    Abruzzo, Lynne
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Borthakur, Gautam
    Stingo, Franceso
    Hu, Peter
    Nguyen, Martin H.
    Fox, Patricia S.
    Medeiros, L. Jeffrey
    Estrov, Zeev
    Bueso-Ramos, Carlos E.
    Cortes, Jorge E.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [49] MOLECULAR MARKERS IN DE NOVO ACUTE MYELOID LEUKEMIA
    Salem, K.
    Alkhail, H. Aba
    HAEMATOLOGICA, 2014, 99 : 567 - 568
  • [50] Natural allelic variants of breast cancer resistance protein (BCRP) and their relationship to BCRP expression in human intestine
    Zamber, CP
    Lamba, JK
    Yasuda, K
    Farnum, J
    Thummel, K
    Schuetz, JD
    Schuetz, EG
    PHARMACOGENETICS, 2003, 13 (01): : 19 - 28
12345